Carroll Financial Associates’s VanEck Pharmaceutical ETF PPH Stock Holding History

Carroll Financial Associates’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-200	Closed	-$11K	–	1201
2016 Q3	$11K	Hold	200	–	–	﹤0.01%	801
2016 Q2	$11K	Hold	200	–	–	﹤0.01%	767
2016 Q1	$11K	Hold	200	–	–	﹤0.01%	747
2015 Q4	$13K	Hold	200	–	–	﹤0.01%	692
2015 Q3	$12K	Hold	200	–	–	﹤0.01%	686
2015 Q2	$14K	Buy	+200	New	+$14.4K	﹤0.01%	640

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Colrain Capital Boston, Massachusetts $259M AUM 63.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

Carroll Financial Associates's PPH Position: Q4 2016 in Review

Carroll Financial Associates sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2016, closing a stake of 200 shares — an estimated $11K sold.

Carroll Financial Associates first reported a position in PPH in Q2 2015 and held it in 6 quarters. The position peaked at $14K in Q2 2015. 51 funds tracked by Wall St. Rank hold PPH as of Q4 2016.

Carroll Financial Associates reported no remaining VanEck Pharmaceutical ETF position as of Q4 2016 after selling out during the quarter.
Carroll Financial Associates sold 200 VanEck Pharmaceutical ETF shares in Q4 2016, an estimated $11K.
Carroll Financial Associates first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and held it in 6 quarters.
Carroll Financial Associates's VanEck Pharmaceutical ETF position peaked at $14K in Q2 2015.
51 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2016.

Based on Carroll Financial Associates's 13F filing for Q4 2016, filed 11 Jan 2017.